Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
Status:
Terminated
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This research study is a Phase II clinical trial, which evaluates a combination of drugs,
FOLFIRINOX and Gemcitabine/Nab-Paclitaxel, in the management of participants with resectable
pancreatic cancer prior to surgery.